| Financial Year |
March 31 2023 |
| Monetary Funds |
55,937,126.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,801,008.08 |
| Accounts Receivable |
562,916,051.80 |
| Advances to Suppliers |
37,796,463.32 |
| Other Receivables |
9,444,853.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
177,804,329.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,930,992.73 |
| Total Current Assets |
951,225,628.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
159,886,887.88 |
| Investment Properties |
-- |
| Fixed Assetes |
71,765,344.89 |
| Under-construction Projects |
16,500,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,634,557.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,073,194.34 |
| Deferred Income Tax Assets |
76,533,553.03 |
| Other Non-Current Assets |
392,992.00 |
| Sub-Total of Non-Current Assets |
364,167,621.06 |
| Total Assets |
1,315,393,249.91 |
| Short-Term Loans |
278,688,322.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
251,208,689.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,943,314.59 |
| Taxes Payable |
44,332,990.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,672,746.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,670,826.22 |
| Other Current Liabilities |
17,929,714.73 |
| Sub-Total of Current Liabilities |
661,531,790.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
676,591.07 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,965,284.48 |
| Total Liabilities |
670,497,075.20 |
| Paid-In Capital(Or Share Stock) |
201,150,000.00 |
| Capital Surplus |
201,398,129.65 |
| Surplus Reserve |
12,790,420.46 |
| LESS:Treasury Stock |
12,109,500.00 |
| Undistributed Profits |
185,512,353.35 |
| Minority Stockholder's Interest |
52,453,977.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
592,442,197.04 |
| Owner's Equity（Stockholder's Equity） |
644,896,174.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,315,393,249.91 |
